The size of the European Cell Sorting Market was worth USD 55.95 Million in 2021. It is further estimated to be growing at a CAGR of 6.49% and worth USD 76.62 Million by 2026.
Cell sorting technologies are used to separate specific cells from a heterogeneous cell mixture. Cell sorting reagent allows the isolation of any cell from any species.
The centrifugation-based cell isolation segment is projected to account for the largest share of the global market in 2018 primarily due to the wide usage of this technique among end-users. This system is used on a large scale by biotechnology and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia for manufacturing vaccines, enzymes, and antibodies. Some of the key technologies such as gradient centrifugation techniques and FACS, chromatography sieving, panning, and lab on a chip are currently under development.
The Europe Cell Sorting Market is driving by factors such as rising demand for cell therapies, higher potential of stem cells, rise in cancer research, technological advancements, rise in chronic diseases, rise in cellular research and disease diagnosis and growing geriatric population worldwide. However, factors such as lack of skilled professionals, cost and size of the equipment of cell sorting are restraining the growth of the market.
This research report on the Europe Cell Sorting Market has been segmented and sub-segmented into the following categories:
By Technology:
By Product:
By Application:
By End User:
By Country:
Some of the notable companies leading the Europe Cell Sorting Market profiled in the report are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, Affymetrix Inc., Sony Biotechnology, Inc., Sysmex Partec GmbH, Cytonome/ST, LLC, On-Chip Biotechnologies Co., Ltd., and Union Biometrica, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Technology
5.1.1 Introduction
5.1.2 FACS
5.1.3 MACS
5.1.4 Microfluids
5.1.5 Y-o-Y Growth Analysis, By Technology
5.1.6 Market Attractiveness Analysis, By Technology
5.1.7 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Cell Sorters
5.2.3 Reagents
5.2.4 Consumables
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3 Application
5.3.1 Introduction
5.3.2 Research
5.3.3 Clinical
5.3.4 Y-o-Y Growth Analysis, By Application
5.3.5 Market Attractiveness Analysis, By Application
5.3.6 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Research Institutes
5.4.3 Biopharma Companies
5.4.4 Medical Schools
5.4.5 Y-o-Y Growth Analysis, By End user
5.4.6 Market Attractiveness Analysis, By End user
5.4.7 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By Application
6.1.5.5 By End user
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Becton, Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories, Inc.
8.3 Beckman Coulter, Inc.
8.4 Miltenyi Biotec GmbH
8.5 Affymetrix Inc.
8.6 Sony Biotechnology, Inc.
8.7 Sysmex Partec GmbH
8.8 Cytonome/ST, LLC
8.9 On-Chip Biotechnologies Co., Ltd.
8.10 Union Biometrica, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Apr 2021
